title: Atypical antipsychotics in children with pervasive developmental disorders.
abstract: The treatment of pervasive developmental disorders (PDDs) is a challenging task, which should include behavioral therapy modifications as well as pharmacologic therapy. There has been a lack of data on using medications in children with PDDs until recent years. Within the last 10 years, an increase in clinical research has attempted to provide efficacy and safety data to support the use of medications in children with PDDs. Double-blinded and open-label research of atypical antipsychotics has been of particular focus. Evidence shows that atypical antipsychotics (AAs) may be useful in treating certain symptoms associated with PDDs, such as aggression, irritability, and self-injurious behavior. This article reviews the literature regarding the use of AAs in children with PDDs. Of the AAs, risperidone has the largest amount of evidence with five published double-blinded, placebo-controlled trials and nine open-label trials. These risperidone trials have consistently shown improvements in aggression, irritability, self-injurious behavior, temper tantrums, and quickly changing moods associated with autistic disorder and other PDDs. Data for the other AAs are limited, but ziprasidone and aripiprazole appear to be promising treatment options. Based on clinical trials, olanzapine and quetiapine have shown minimal clinical benefit and a high incidence of weight gain and sedation. It should be noted that all AAs do have a risk of metabolic syndrome, and patients should be monitored appropriately while receiving these medications. Overall, AAs can be beneficial in alleviating behavioral symptoms, and should be considered an appropriate therapeutic option, as part of a comprehensive treatment strategy, for children with PDD.
authors: Rutgers, State University of New Jersey, Piscataway, New Jersey, USA. bchavez@rci.rutgers.edu
authors: Benjamin
authors: B
authors: Chavez
authors: Mapy
authors: M
authors: Chavez-Brown
authors: Michael A
authors: MA
authors: Sopko
authors: Jose A
authors: JA
authors: Rey
mesh_terms: D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D002675:Child, Preschool; D015897:Comorbidity; D018849:Controlled Clinical Trials as Topic; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism
chemical_list: D014150:Antipsychotic Agents; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine
references: J Autism Dev Disord. 2004 Apr;34(2):163-75
references: 15162935
references: Schizophr Bull. 1982;8(2):320-32
references: 6126001
references: Neuropsychology. 2006 Jan;20(1):21-9
references: 16460219
references: J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):431-9
references: 16601648
references: J Clin Psychiatry. 2005 Dec;66(12):1592-7
references: 16401163
references: Am J Med Genet. 2001 May 8;105(4):381-6
references: 11378854
references: Ann Pharmacother. 2006 May;40(5):909-16
references: 16684811
references: Biol Psychiatry. 2007 Feb 15;61(4):545-50
references: 16730335
references: Mol Interv. 2004 Apr;4(2):109-23
references: 15087484
references: J Clin Psychiatry. 2000 Apr;61(4):252-60
references: 10830145
references: J Clin Psychopharmacol. 2000 Apr;20(2):220-5
references: 10770461
references: J Clin Psychiatry. 1994 Sep;55 Suppl B:27-9
references: 7961567
references: J Child Psychol Psychiatry. 1987 Nov;28(6):885-900
references: 3436995
references: J Pediatr. 1961 Mar;58:315-20
references: 13747230
references: Child Dev. 1999 Jul-Aug;70(4):817-32
references: 10446722
references: Neurol Clin. 2003 Nov;21(4):915-32, viii
references: 14743656
references: Nat Genet. 2007 Jan;39(1):25-7
references: 17173049
references: Child Care Health Dev. 2006 Sep;32(5):511-9
references: 16919130
references: J Am Acad Child Adolesc Psychiatry. 1997 May;36(5):685-93
references: 9136504
references: J Child Adolesc Psychopharmacol. 2004 Fall;14(3):455-63
references: 15650503
references: J Child Adolesc Psychopharmacol. 1999;9(2):99-107
references: 10461820
references: J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2):140-7
references: 11837403
references: J Child Neurol. 2004 Mar;19(3):155-64
references: 15119475
references: J Am Acad Child Adolesc Psychiatry. 2005 Nov;44(11):1137-44
references: 16239862
references: J Autism Dev Disord. 2007 Feb;37(2):210-7
references: 16865547
references: Science. 1999 May 14;284(5417):1155-8
references: 10325223
references: J Child Adolesc Psychopharmacol. 2006 Oct;16(5):541-8
references: 17069543
references: Am J Ment Retard. 1997 Nov;102(3):238-49
references: 9394133
references: J Child Neurol. 2006 Jun;21(6):450-5
references: 16948927
references: Diabetes Care. 2004 Feb;27(2):596-601
references: 14747245
references: J Pharmacol Exp Ther. 1988 Nov;247(2):661-70
references: 2460616
references: Nat Neurosci. 2006 Oct;9(10):1218-20
references: 17001340
references: Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):23-42, viii
references: 10674189
references: J Child Adolesc Psychopharmacol. 1996 Fall;6(3):177-90
references: 9231311
references: Am J Psychiatry. 1996 May;153(5):738
references: 8615435
references: J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):720-8
references: 16721322
references: Hum Mol Genet. 1997 Dec;6(13):2233-8
references: 9361027
references: J Clin Psychopharmacol. 1999 Feb;19(1):37-44
references: 9934941
references: J Am Acad Child Adolesc Psychiatry. 2001 Aug;40(8):887-94
references: 11501687
references: J Clin Psychiatry. 1994 Sep;55 Suppl B:47-52
references: 7961573
references: Psychopharmacol Bull. 1997;33(1):155-9
references: 9133768
references: Life Sci. 2000 Aug 25;67(14):1667-82
references: 11021352
references: J Child Adolesc Psychopharmacol. 2004 Summer;14(2):287-94
references: 15319025
references: J Am Acad Child Adolesc Psychiatry. 2002 Dec;41(12):1513-6
references: 12447040
references: J Clin Psychopharmacol. 2003 Feb;23 (1):87-91
references: 12544379
references: J Am Acad Child Adolesc Psychiatry. 2002 Aug;41(8):921-7
references: 12164181
references: Synapse. 1990;6(3):292-308
references: 1700486
references: J Int Neuropsychol Soc. 2006 May;12(3):314-26
references: 16903124
references: Arch Gen Psychiatry. 1996 Nov;53(11):1001-8
references: 8911223
references: J Autism Dev Disord. 2006 Jul;36(5):697-704
references: 16614791
references: Am J Med Genet. 2002 Apr 8;114(3):277-83
references: 11920848
references: J Am Acad Child Adolesc Psychiatry. 2002 Nov;41(11):1380-3
references: 12410082
references: J Child Adolesc Psychopharmacol. 2000 Summer;10(2):79-90
references: 10933118
references: Am J Psychiatry. 2005 Jun;162(6):1142-8
references: 15930063
references: Psychiatr Clin North Am. 1991 Mar;14(1):165-82
references: 1675463
references: J Child Adolesc Psychopharmacol. 2006 Oct;16(5):575-87
references: 17069546
references: N Engl J Med. 2002 Aug 1;347(5):314-21
references: 12151468
references: J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84
references: 16379507
references: Am J Psychiatry. 2005 Jul;162(7):1361-9
references: 15994720
references: J Clin Psychiatry. 1996;57 Suppl 11:4-11
references: 8941166
references: Pediatrics. 2006 Jul;118(1):e139-50
references: 16818529
references: J Clin Psychiatry. 2003 Nov;64(11):1362-9
references: 14658952
references: J Clin Psychiatry. 2001 Jun;62(6):479-80
references: 11465533
references: Behav Modif. 2002 Jan;26(1):49-68
references: 11799654
references: J Clin Psychopharmacol. 2002 Oct;22(5):455-60
references: 12352267
references: J Am Acad Child Adolesc Psychiatry. 1998 Apr;37(4):372-6
references: 9549957
references: Am J Psychiatry. 2006 Dec;163(12):2148-56
references: 17151167
references: J Autism Dev Disord. 1997 Jun;27(3):313-23
references: 9229261
references: J Child Adolesc Psychopharmacol. 2001 Fall;11(3):229-38
references: 11642473
references: Pediatrics. 2004 Nov;114(5):e634-41
references: 15492353
references: J Autism Dev Disord. 2003 Oct;33(5):509-17
references: 14594330